Law & policy

Latest content

Allergan scores victory in trailblazing US patent fraud whistle-blower suit

Ninth Circuit Court of Appeal puts the breaks on whistleblower’s attempts to show deception in company’s dealings with the USPTO

01 September 2022

How the UPC will change the global patent litigation landscape

This time next year, the new EU system is almost certain to be up and running. For rights holders and potential defendants, it will mean rethinking long-established strategic choices and preparing for a new set of major challenges. Gwilym Roberts, David Rose and Suzanne Harrison explain why 'game changing' may not be too hyperbolic a way to describe what is approaching

31 August 2022

Why the new CHIPS + Science Act matters for IP

Although many provisions were stripped out of the final version of the legislation, it still contains important tech transfer-related elements, while the huge sums for R&D it envisages are almost certain to spawn more patents

30 August 2022

Case against FDA may shed light on long-running Orange Book uncertainty

Doubts over whether REMS patents can be listed could be clarified in a case brought by Avadel CNS Pharmaceuticals in Washington DC

30 August 2022

IPR estoppel has teeth in 2022

The Federal Circuit’s recent decisions represent the pendulum swinging to favour patent owners

25 August 2022

Top university IP head voices concerns about new UK foreign investment law

Imperial College tech transfer chief Vjera Magdalenic-Moussavi says the recent legislation puts dealmaking in danger

23 August 2022

The five challenges that will define the Campinos legacy at the EPO

The Portuguese president of the agency was recently appointed to a second term and now has until the end of June 2028 to leave an indelible mark on Europe’s patent story

18 August 2022

Why brand-name pharmaceuticals should look to China’s patent linkage system

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

China has recently introduced a unique patent linkage system, which has opened up fresh opportunities for those brand-name pharmaceutical companies that adapt their IP strategies to it.

18 August 2022

Tips and tricks on how to obtain patent protection for polymorphs

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

Obtaining patent protection for a polymorph in addition to a primary compound patent may be particularly advantageous, especially if filed successively, as the polymorph patent may add extra time to the patent protection for the modification of an approved drug or a clinical candidate.

18 August 2022

What made Colombia an attractive venue for Ericsson in its patent battle with Apple

The Swedish company has been a prolific filer in a country whose judicial processes strongly favour plaintiffs

11 August 2022

Unlock unlimited access to all IAM content